1 of 1
Story summary
- Eli Lilly and Company (Lilly) announced that some Medicare beneficiaries may pay more than the $50 monthly cap for weight-loss drugs.
- Most Medicare Part D plans are expected to honor the cap, though a few may not fully comply.
- Starting January 1, 2027, GLP-1 drugs will be available through Medicare Part D plans under a Centers for Medicare and Medicaid Services expansion.
